Pharmaceuticals and Medical Devices Agency

Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk

Philip Urban, Roxana Mehran, Róisín Colleran et al. · European Heart Journal · 2019 · 540 citations · Full text

Evaluation and Treatment of Patients With Lower Extremity Peripheral Artery Disease

Manesh R. Patel, Michael S. Conte, Donald E. Cutlip et al. · Journal of the American College of Cardiology · 2015 · 358 citations · Full text

Thrombosis, Cardiovascular Disease, Peripheral Intervention +10

Efficient Generation of Functional Hepatocytes From Human Embryonic Stem Cells and Induced Pluripotent Stem Cells by HNF4α Transduction

Kazuo Takayama, Mitsuru Inamura, Kenji Kawabata et al. · Molecular Therapy · 2011 · 231 citations · Full text

Quantitative Comparison of Intracellular Trafficking and Nuclear Transcription between Adenoviral and Lipoplex Systems

Susumu Hama, Hidetaka Akita, Rie Ito et al. · Molecular Therapy · 2005 · 211 citations

Cytotoxic Activity of Tivantinib (ARQ 197) Is Not Due Solely to c-MET Inhibition

Ryohei Katayama, Aki Aoyama, Takao Yamori et al. · Cancer Research · 2013 · 208 citations · Full text

Immunology, Cellular Pharmacology, Pharmacotherapy +18